Synthesis and Activity‐Based Protein Profiling Identifies Aldo‐Keto Reductase 1C3 as Target Protein of Myxoglucamides
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.6489568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Thomas Siemon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Biology, Helmholtz-Centre for Infection Research (HZI), Braunschweig, Germany. Hauptthemen laut MEDLINE: Hydroxyprostaglandin Dehydrogenases, 3-Hydroxysteroid Dehydrogenases, Enzyme Inhibitors, Biological Products. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myxoglucamides, natural products recently isolated from Cystobacterineae sp., are featured by an unprecedented vinyl‐substituted α‐keto‐γ‐amino acid that is linked to a glycosylated 14‐methyl‐pentadecanoic acid. Thus, they unite elements from three biomolecular classes in a compact glycolipopeptide. To elucidate the biological relevance of this arrangement, we searched for molecular targets by activity‐based protein profiling (ABPP)—although a phenotypic bioactivity has not been reported. An access to the compound class was established through the first total synthesis of myxoglucamide A in 11 steps. A proteome‐wide ABPP study led to the identification of aldo‐keto reductase 1C3 (AKR1C3) as the primary target of myxoglucamides in human cells. AKR1C3 is an oncogenic factor involved in prostaglandin and steroid synthesis, promoting the growth, proliferation, and metastasis of carcinoma cells. The functional inhibition of AKR1C3 by a competitive mechanism (IC 50 = 1.61 µ m ) was validated in vitro, and 20 analogs provided structure‐activity relationships and more potent analogs (IC 50 = 181 n m ). Biophysical interactions were quantified by thermal shift assays, and essential molecular protein‐ligand interactions were characterized by X‐ray crystallography at 2.0 Å resolution. The study implies that the search for targets of natural products is rewarding even in the absence of an initial phenotypic activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Biology, Helmholtz-Centre for Infection Research (HZI), Braunschweig, Germany.
- Department of Structure and Function of Proteins, Helmholtz-Centre for Infection Research (HZI), Braunschweig, Germany.
- Helmholtz-Institute For Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy (HZI), Saarland University, Campus E8.1, Saarbrücken, Germany.
- Research Group Cellular Proteome Research, Helmholtz-Centre For Infection Research (HZI), Braunschweig, Germany.
- Institute of Organic Chemistry and Centre of Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Hannover, Germany.
- German Center for Infection Research, Site Hannover-Braunschweig, Braunschweig, Germany.
ORCID-Profile: Chengzhang Fu, Mark Brönstrup
Zitieren
APA
Siemon, T., Mishra, V. K., Zhao, M., Büssow, K., Popoff, A., Fu, C., Müller, R., Jänsch, L., Blankenfeldt, W., & Brönstrup, M. (2026). Synthesis and Activity‐Based Protein Profiling Identifies Aldo‐Keto Reductase 1C3 as Target Protein of Myxoglucamides. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.6489568
Vancouver
Siemon T, Mishra VK, Zhao M, Büssow K, Popoff A, Fu C, et al. Synthesis and Activity‐Based Protein Profiling Identifies Aldo‐Keto Reductase 1C3 as Target Protein of Myxoglucamides. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.6489568
BibTeX
@article{Siemon2026,
author = {Siemon, Thomas and Mishra, Vivek K and Zhao, Mingming and Büssow, Konrad and Popoff, Alexander and Fu, Chengzhang and Müller, Rolf and Jänsch, Lothar and Blankenfeldt, Wulf and Brönstrup, Mark},
title = {Synthesis and Activity‐Based Protein Profiling Identifies Aldo‐Keto Reductase 1C3 as Target Protein of Myxoglucamides},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.6489568}
}
EUVIMED